Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness and Safety of Penehyclidine Hydrochloride for Improving Microcirculatory Dysfunction in Critically Ill Children
Sponsor: Lihua Wen
Summary
This prospective randomized controlled trial was designed to evaluate whether the M1/M3-selective antagonist penehyclidine hydrochloride could more effectively reverse pediatric microcirculatory dysfunction than traditional atropine, particularly when macrohemodynamics appear normalized.
Official title: Effectiveness and Safety of Penehyclidine Hydrochloride for Improving Microcirculatory Dysfunction in Critically Ill Children: A Single-Center, Prospective, Randomized Controlled Trial
Key Details
Gender
All
Age Range
28 Days - 18 Years
Study Type
INTERVENTIONAL
Enrollment
98
Start Date
2024-05-08
Completion Date
2026-03-01
Last Updated
2026-04-09
Healthy Volunteers
No
Conditions
Interventions
atropine control group
atropine control group
penehyclidine hydrochloride group
penehyclidine hydrochloride
Locations (1)
Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, China